Drug Design and Synthesis Core

NIH RePORTER · NIH · P30 · $202,694 · view on reporter.nih.gov ↗

Abstract

SUMMARY The Drug Design and Synthesis Core (DDSC) is key to the mission and overall success of the COBRE Center for Targeted Therapeutics (CTT) and made key contributions to the success of Phases 1 and 2. Its mission is to provide expertise to investigators in evaluation of biological targets for druggability, to assist them in synthesizing chemical analogs that can be used in drug development and furthermore in designing viable strategies for drug discovery and optimization. DDSC is the only chemical synthesis core facility operating at USC and provides unique services to interested investigators. In accomplishing the specific aims, the DDSC will enable investigators to maximize the funding potential and scientific outcomes of their research progress while leading to potential new therapeutic options for challenging diseases, conditions, and illnesses.

Key facts

NIH application ID
10936196
Project number
1P30GM154632-01
Recipient
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
Principal Investigator
Campbell McInnes
Activity code
P30
Funding institute
NIH
Fiscal year
2024
Award amount
$202,694
Award type
1
Project period
2024-07-15 → 2029-05-31